Indoor Biotechnologies was founded by Dr. Martin D. Chapman, formerly Professor of Medicine and Microbiology at the University of Virginia and a member of the UVA Asthma and Allergic Diseases Center. Dr. Chapman is a Fellow of the American Academy of Allergy, Asthma and Immunology and has served as a consultant to the U.S. National Institutes of Health, the Environmental Protection Agency, academic institutions and Fortune 500 companies..

Indoor Biotechnologies specializes in manufacturing biologics for allergy and asthma. The company is recognized as the world leader in assessment of environmental exposure to allergens - in the home, workplace, schools and commercial buildings. The company manufactures highly purified allergens for allergy research and diagnostics, and is internationally recognized for research on allergen structure, function and immune recognition. Indoor Biotechnologies mission is to improve the quality of life of patients with allergy and asthma.

FITkit Hev b 1 CAT K3-350-020 Brochure

Contact supplier